Patents by Inventor Ranjan Dohil

Ranjan Dohil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20160331705
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 27, 2016
    Publication date: November 17, 2016
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20160151310
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: November 24, 2015
    Publication date: June 2, 2016
    Inventors: Ranjan Dohil, Jerry Schneider
  • METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE PRODUCTS
    Publication number: 20160143865
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: September 28, 2015
    Publication date: May 26, 2016
    Inventors: Ranjan Dohil, Jerry Schneider
  • VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
    Publication number: 20160045518
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: July 28, 2015
    Publication date: February 18, 2016
    Inventors: Ranjan Dohil, John Bastian, Seema S. Aceves, Elaine Phillips, Malcolm Hill
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9198882
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: December 1, 2015
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Enterically coated cysteamine, cystamine and derivatives thereof
    Patent number: 9192590
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: November 24, 2015
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20150290150
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: June 26, 2015
    Publication date: October 15, 2015
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20150290149
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: June 26, 2015
    Publication date: October 15, 2015
    Inventors: Ranjan Dohil, Jerry Schneider
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20150283100
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: November 28, 2014
    Publication date: October 8, 2015
    Applicant: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
    Patent number: 9149448
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: October 6, 2015
    Assignee: The Regents of the University Of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 9119863
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: September 1, 2015
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, John Bastian, Seema S. Aceves, Elaine Phillips, Malcolm Hill
  • Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 8975243
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: March 10, 2015
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, John Bastian, Seema S. Aceves
  • CYSTEAMINE AND/OR CYSTAMINE FOR TREATING ISCHEMIC INJURY
    Publication number: 20140322315
    Abstract: Provided herein are methods and compositions for treating ischemia or a disease or disorder that causes ischemia comprising contacting a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative. The disclosure also provides methods of modulating adiponectin levels in a subject comprising contact a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative.
    Type: Application
    Filed: November 21, 2012
    Publication date: October 30, 2014
    Applicant: The Regents of the University of California
    Inventors: Ranjan Dohil, Susan A. Phillips
  • TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
    Publication number: 20140187523
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: January 3, 2014
    Publication date: July 3, 2014
    Applicants: Meritage Pharma, Inc., The Regents of the University of California
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 8679545
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: March 25, 2014
    Assignees: The Regents of the University of California, Meritage Pharma, Inc.
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves
  • VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
    Publication number: 20130296286
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Application
    Filed: July 8, 2013
    Publication date: November 7, 2013
    Inventors: Ranjan Dohil, John Bastian, Seema S. Aceves, Elaine Phillips, Malcolm Hill
  • Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 8497258
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: July 30, 2013
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, John Bastian, Seema Aceves, Elaine Phillips, Malcolm Hill
  • METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE PRODUCTS
    Publication number: 20130183351
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: September 10, 2012
    Publication date: July 18, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Ranjan Dohil, Jerry Schneider
  • Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 8324192
    Abstract: Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
    Type: Grant
    Filed: November 9, 2006
    Date of Patent: December 4, 2012
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, John Bastian, Seema S. Aceves
  • ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
    Publication number: 20120237599
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: February 17, 2012
    Publication date: September 20, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Ranjan Dohil, Jerry Schneider